2017;38:766 772. doi: 10.3174/ajnr.A5095 of glucocorticoid-resistant or relapsing Takayasu arteritis with methotrex- ate. Arthritis Rheum. 1994;37:578 582. doi: 10.1002/art.1780370420 688. Valsakumar AK, Valappil UC, Jorapur V, Garg N, Nityanand S, Sinha N. Role of immunosuppressive therapy on clinical, immunological, and angiographic outcome in active Takayasu s arteritis. J Rheumatol. 2003;30:1793 1798. 689. de Souza AW, de Almeida Agustinelli R, de Cinque Almeida H, Oliveira PB, Pinheiro FA, Oliveira AC, Sato EI. Leflunomide in Takayasu arteritis: a long term observational study. Rev Bras Reumatol Engl Ed. 2016;56:371 375. 690. Salvarani C, Cantini F, Boiardi L, Hunder GG. Polymyalgia rheumat- ica and giant-cell arteritis. N Engl J Med. 2002;347:261 271. doi: 691. Salvarani C, Brown RD Jr, Calamia KT, Christianson TJ, Weigand SD, Miller DV, Giannini C, Meschia JF, Huston J 3rd, Hunder GG. Primary central nervous system vasculitis: analysis of 101 patients. Ann Neurol. 692. Boulouis G, de Boysson H, Zuber M, Guillevin L, Meary E, Costalat V, Pagnoux C, Naggara O; French Vasculitis Group. Primary angiitis of the central nervous system: magnetic resonance imaging spectrum of parenchymal, meningeal, and vascular lesions at baseline. Stroke. 693. Hutchinson C, Elbers J, Halliday W, Branson H, Laughlin S, Armstrong D, Hawkins C, Westmacott R, Benseler SM. Treatment of small vessel pri- mary CNS vasculitis in children: an open-label cohort study. Lancet Neurol. 694. Salvarani C, Brown RD Jr, Christianson TJ, Huston J 3rd, Giannini C, Miller DV, Hunder GG. Adult primary central nervous system vasculitis treat- ment and course: analysis of one hundred sixty-three patients. Arthritis 695. de Boysson H, Arquizan C, Touz E, Zuber M, Boulouis G, Naggara O, Guillevin L, Aouba A, Pagnoux C. Treatment and long-term outcomes of primary central nervous system vasculitis. Stroke. 2018;49:1946 1952. 696. 